{"brief_title": "Efficacy and Safety of Zoledronic Acid for the Treatment of Osteoporosis in Men", "brief_summary": "The goal of this study is to determine the effectiveness and safety of an annual intravenous treatment of zoledronic acid for the treatment of osteoporosis in men. All patients will receive calcium and vitamin D supplements.", "condition": "Osteoporosis", "intervention_type": "Drug", "intervention_name": "Zoledronic Acid", "criteria": "Inclusion Criteria: - Male, 25-85 years old Exclusion Criteria: - Current users of bisphosphonates such as Aredia\u00ae (pamidronate), Didronel\u00ae (etidronate), Fosamax\u00ae (alendronate), Actonel \u00ae (residronate), Skelid\u00ae (tiludronate) - History of severe liver, kidney or eye disease Other protocol-defined inclusion/exclusion criteria may apply.", "gender": "Male", "minimum_age": "25 Years", "maximum_age": "85 Years", "healthy_volunteers": "No", "id": "NCT00097825.xml"}